Bunkerhill AVC vs Zio AT ECG Monitoring System

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Bunkerhill Health
VS
by iRhythm Technologies, Inc.

AI Verdict

Tool A (Bunkerhill AVC) specializes in AI-powered detection and quantification of cardiac calcifications and opportunistic bone density from CT scans, integrating with EHRs for clinical reasoning. In contrast, Tool B (Zio AT ECG Monitoring System) offers continuous, wearable ECG monitoring with AI for long-term arrhythmia detection. While both are cardiology AI tools, they address distinct diagnostic needs: Bunkerhill AVC focuses on imaging analysis for structural issues, whereas Zio AT focuses on remote monitoring for electrical abnormalities.

Choose Bunkerhill AVC if…

Choose Bunkerhill AVC if your health system aims to leverage existing chest CT scans for opportunistic screening and early detection of cardiovascular diseases. This tool is ideal for automatically identifying and quantifying aortic valve, coronary artery, and mitral annular calcifications, as well as bone density, directly from imaging data integrated with your EHR. It empowers radiologists and cardiologists to proactively identify at-risk patients who might otherwise go undiagnosed.

View Bunkerhill AVC →

Choose Zio AT ECG Monitoring System if…

Choose the Zio AT ECG Monitoring System if you need a comprehensive, long-term solution for detecting and characterizing cardiac arrhythmias in an ambulatory setting. This wearable device provides continuous ECG monitoring for up to 14 days, making it particularly effective for patients experiencing intermittent symptoms or those requiring extended surveillance for suspected rhythm disorders. It offers detailed, AI-powered reports to aid in the diagnosis and management of various cardiac events.

View Zio AT ECG Monitoring System →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Bunkerhill AVC Zio AT ECG Monitoring System
Pricing Unknown Contact for pricing
Deployment Unknown Cloud-based (data analytics and clinician portal)
BAA Available Yes AI-estimated Yes AI-estimated
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Bunkerhill AVC

Tool A emphasizes deep integration with existing EHRs and clinical archives, offering features like customizable AI agents and natural language processing for patient record interaction. This approach aims to provide a more seamless experience for clinicians within their established workflows, potentially reducing the need to learn new systems or switch contexts. Tool B, while designed for ease of use, introduces new patient-worn hardware and separate clinician portals.

Clinical Value

Bunkerhill AVC

Both tools offer significant, FDA-cleared clinical value. However, Tool A's ability to opportunistically screen for multiple cardiovascular and bone density conditions (aortic valve calcification, coronary artery calcification, mitral annular calcification, and bone density) from a single, commonly performed imaging study (chest CT) provides a broader impact on population health and early detection of previously undiagnosed conditions. Tool B is highly valuable for targeted arrhythmia detection through continuous ECG monitoring.

Pricing & Value

Tie

Neither Tool A nor Tool B publicly discloses its pricing structure, making a direct comparison of pricing and value impossible. Both require direct contact for pricing information, which is typical for enterprise healthcare solutions that often involve customized service agreements and licensing models.

Enterprise Readiness

Bunkerhill AVC

Both tools are FDA-cleared, HIPAA compliant, and offer Business Associate Agreements (BAAs), indicating strong readiness for healthcare environments. However, Tool A's explicit focus on deep integration with full Electronic Health Records (EHRs) and clinical archives, along with its design to automate workflows within existing systems, suggests a potentially smoother and more comprehensive adoption within large health systems' IT infrastructure.

Innovation

Bunkerhill AVC

While both utilize advanced AI, Tool A's emphasis on 'Generative AI for clinical reasoning and action,' 'customizable AI agents for diverse workflows,' and 'natural language processing for patient record interaction' represents a more advanced and adaptable form of AI application in healthcare. This goes beyond mere detection to assist with complex decision-making and broader workflow automation.

Support & Docs

Zio AT ECG Monitoring System

Tool B (Zio AT) offers a more transparent and readily accessible suite of support documentation, including detailed 'Instructions for Use,' 'Clinical Reference Manuals,' and extensive FAQ sections with troubleshooting guides for both patients and healthcare providers, along with direct customer support contact. Tool A's publicly available information does not detail similar dedicated support resources.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Bunkerhill AVC Zio AT ECG Monitoring System
Name Bunkerhill AVC Zio AT ECG Monitoring System
Company BunkerHill Health iRhythm Technologies, Inc.
Description Bunkerhill Health provides a generative AI platform, Carebricks, for clinical reasoning and action, integrating with EHRs to automate workflows and improve patient outcomes. Its FDA-cleared algorithm, Bunkerhill AVC, specifically aids in the early detection and quantification of aortic valve calcification from chest CTs. The Zio AT ECG Monitoring System by iRhythm Technologies is an FDA-cleared, wearable mobile cardiac telemetry (MCT) service offering continuous, AI-powered ECG monitoring for long-term arrhythmia detection and comprehensive reporting.
Categories Cardiology AI, Clinical Decision Support & Reference Cardiology AI, Wearables & Remote Monitoring (RPM)
Specialties Cardiology, Radiology Cardiology
Key Features (Primary Focus) Automated detection and quantification of aortic valve calcification (Bunkerhill AVC) Continuous, uninterrupted ECG recording for up to 14 days

Videos

Demos, reviews, and walkthroughs featuring Bunkerhill AVC and Zio AT ECG Monitoring System.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Bunkerhill AVC primarily focuses on the automated detection and quantification of various calcifications, such as aortic valve, coronary artery, and mitral annular calcification, as well as opportunistic bone density assessment, from chest CTs. In contrast, the Zio AT ECG Monitoring System is designed for continuous, AI-powered ECG monitoring to detect long-term arrhythmias.
Bunkerhill AVC integrates with full Electronic Health Records (EHRs) and clinical archives within health systems to analyze existing chest CT scans. The Zio AT ECG Monitoring System utilizes a wearable Zio AT patch for continuous ECG recording and a wireless gateway for real-time data transmission.
Bunkerhill AVC employs generative AI for clinical reasoning and action, including natural language processing for patient record interaction, with FDA-cleared algorithms for calcification detection and quantification. The Zio AT ECG Monitoring System features an FDA-cleared deep-learned AI algorithm (ZEUS System) specifically for arrhythmia detection from continuous ECG data.
Bunkerhill AVC integrates directly with full Electronic Health Records (EHRs) and clinical archives within health systems, offering customizable AI agents for diverse workflows. The Zio AT ECG Monitoring System operates as a cloud-based service, providing a ZioSuiteu00ae clinician portal and mobile app for patient management and report interpretation.
Bunkerhill AVC provides automated detection and quantification of various calcifications and opportunistic bone density assessments from CT scans. The Zio AT ECG Monitoring System delivers comprehensive end-of-wear reports for clinicians, detailing detected symptomatic and asymptomatic cardiac events.
Bunkerhill AVC is designed for Cardiology and Radiology specialties, and can also support Primary Care for opportunistic findings. The Zio AT ECG Monitoring System is primarily designed for Cardiology.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.